105224-25-7Relevant articles and documents
Fused tricyclic compound and application in medicines
-
Paragraph 0352-0357, (2020/06/17)
The invention relates to a condensed tricyclic compound and application in medicines, particularly to application of the condensed tricyclic compound as a medicine for treating and/or preventing hepatitis B. Specifically the present invention relates to a
First synthesis of 5-cyanosalicylates by formal [3+3] Cyclocondensations of 1,3-Bis(silyloxy)-1,3-butadienes
Riahi, Abdolmajid,Fatunsin, Olumide,Shkoor, Mohanad,Dede, Ruediger,Reinke, Helmut,Fischer, Christine,Langer, Peter
experimental part, p. 1623 - 1634 (2009/12/10)
A variety of functionalized benzonitriles were regioselectively prepared by formal [3+3] cyclocondensation of 1,3-bis(silyloxy)-1,3-butadienes with 3-ethoxy- and 3-silyloxy-2-cyano-2-en-1-ones. Georg Thieme Verlag Stuttgart.
4-AMINOETHYLENE DERIVATIVES OF 2-METHYLBENZOTRIAZOLE
Milata, Viktor,Ilavsky, Dusan,Goljer, Igor,Lesko, Jan,Chahinian, Marc,Henry-Basch, Erica
, p. 1038 - 1048 (2007/10/02)
N-Methylation of 4(7)-nitrobenzotriazole (I) afforded a mixture of three isomers; one of them, 4-nitro-2-methylbenzotriazole (II) could easily be isolated.Catalytical hydrogenation of II led to the corresponding amine which in turn, afforded products of nucleophilic substitution IVa-IVi on reaction with alkoxymethylene derivatives IIIa - IIIi.Thermal cyclocondensation of IVi yielded 7-ethoxycarbonyl-6,9-dihydro-6-oxo-2-methyl-2H-triazoloquinoline (V).The structure of all products was deduced from the IR, UV, 1H and 13C NMR spectral data.